Sweeny Nicole 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Sweeny Nicole（CIK 1827505）在 1 家公司共报告 17 笔 SEC Form 4 内部人交易（最近一笔 2026-06-11）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-06-11 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 卖出 | 59,291 | $0 |
| 2026-05-27 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 卖出 | 1,489 | $39,875 |
| 2026-05-27 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 5,000 | $0 |
| 2026-05-26 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 6,250 | $0 |
| 2026-05-26 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 卖出 | 1,861 | $49,838 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 6,250 | $0 |
| 2026-04-20 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 卖出 | 1,862 | $37,650 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 6,250 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 5,000 | $0 |
| 2026-02-24 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 卖出 | 3,975 | $61,891 |
| 2025-12-04 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 6,250 | $0 |
| 2025-12-04 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 5,000 | $0 |
| 2025-12-04 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 卖出 | 3,813 | $51,285 |
| 2025-08-26 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 5,000 | $0 |
| 2025-08-26 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 卖出 | 1,480 | $19,862 |
| 2025-08-25 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 卖出 | 1,864 | $24,642 |
| 2025-08-25 | KalVista Pharmaceuticals, Inc. (KALV) | Chief Commercial Officer | 买入 | 6,250 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-06-11